Self-engineered binary nanoassembly enabling closed-loop glutathione depletion-amplified tumor ferroptosis

. As expected, this uniquely engineered dual-drug nanoassembly demonstrates vigorous antitumor activity in 4T1 breast tumor-bearing mice. This study presents a novel nanotherapeutic modality for ferroptosis-driven cancer treatment.